Medpace Holdings (MEDP) Net Margin (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Net Margin data on file, last reported at 17.16% in Q2 2026.

• Quarterly Net Margin rose 220.0% year-over-year to 17.16% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 17.67% (down 108.0% YoY) and the FY2025 annual result came in at 17.83%, down 134.0% from the prior year.
• Net Margin declined to 17.16% in Q2 2026, from 17.53% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 21.81% in Q4 2024 to a low of 13.25% in Q2 2023.
• A 5-year average of 17.23% and a median of 17.18% in 2022 frame the typical range for Net Margin.
• Annual changes were most pronounced in 2024 — Net Margin surged 610 bps — and 2026, when it sank 299 bps.
• Tracing MEDP's Net Margin over 5 years: stood at 17.42% in 2022, then fell by 10 bps to 15.71% in 2023, then soared by 39 bps to 21.81% in 2024, then retreated by 13 bps to 19.07% in 2025, then retreated by 10 bps to 17.16% in 2026.
• The last three Net Margin figures came in at 17.16% (Q2 2026), 17.53% (Q1 2026), and 19.07% (Q4 2025), per Business Quant data.